Background
Methods
Design
Participants and setting
Randomization
Intervention
Clinical outcomes
Costs measures
Cost category | Unit | Unit costs (2013)a
|
---|---|---|
General practitioner | Contact | €30.64 |
Company physician | Contact | €32.26 |
Medical specialist | Contact | €78.33 |
Occupational or physiotherapist | Contact | €39.16 |
Social worker | Contact | €70.71 |
Psychologist or psychiatrist in private practice | Contact | €87.03 |
Psychologist or psychiatrist in hospital | Contact | €186.03 |
Mental healthcare institute worker | Contact | €186.03 |
Alternative healer | Contact | €44.67 |
Day treatment for mental care | Day | €167.54 |
Admission to regular hospital | Day | €473.23 |
Admission to academic hospital | Day | €625.54 |
Admission to psychiatric hospital | Day | €252.39 |
Admission to rehabilitation center | Day | €369.89 |
Admission to nursing home | Day | €258.92 |
Admission to other healthcare institutionb
| Day | €497.17 |
Homecare | Hour | €38.07 |
Informal care | Hour | €13.50 |
Statistical analyses
Sensitivity analysis
Results
Participant flow
Patient characteristics measured at baseline | Stepped-care (n = 131) | Usual care (n = 134) | |
---|---|---|---|
Gender (female) (n (%)) | 91 (69%) | 94 (70%) | |
Age (years) range [50–98] (mean (SD)) | 72.4 (12.5) | 74.9 (11.9) | |
Education (years) range [0–16] (mean (SD)) | 10.4 (3.8) | 9.3 (3.4) | |
Having work (n (%)) | 15 (12%) | 7 (5%) | |
Nationality (n (%)) | Dutch | 116 (89%) | 117 (87%) |
Belgian | 14 (11%) | 16 (12%) | |
Other | 1 (1%) | 1 (1%) | |
Living situation (independent) (n (%)) | 115 (88%) | 124 (93%) | |
Income (n (%)) | Usually enough money | 61 (47%) | 62 (46%) |
Just enough money | 55 (42%) | 57 (43%) | |
Not enough money | 10 (8%) | 15 (11%) | |
Cause of vision loss (n (%)) | Macular degeneration | 62 (47%) | 60 (45%) |
Glaucoma | 26 (20%) | 19 (14%) | |
Cataract | 26 (20%) | 19 (14%) | |
Diabetic retinopathy | 5 (4%) | 4 (3%) | |
Cerebral hemorrhage | 5 (4%) | 10 (8%) | |
Other | 45 (34%) | 60 (45%) | |
Time of onset (years) range [0–79] (mean (SD)) | 16.0 (19.6) | 14.4 (18.2) | |
LogMAR visual acuity (n (%)) | Normal visual acuity | 9 (7%) | 15 (11%) |
Mild vision loss | 24 (18%) | 23 (17%) | |
Low vision / blindness | 86 (66%) | 86 (64%) | |
Comorbidity range [0–5] (mean (SD)) | 1.1 (1.2) | 1.2 (1.2) | |
History of major depressive disorder (n (%)) | 30 (23%) | 25 (19%) | |
History of dysthymic disorder (n (%)) | 4 (3%) | 1 (1%) | |
History of panic disorder (n (%)) | 8 (6%) | 8 (6%) | |
Baseline CES-D score (mean(SD)) | 21.2 (6.4) | 21.1 (6.7) | |
Baseline HADS-A score (mean(SD)) | 7.1 (4.1) | 7.1 (3.8) | |
Baseline EQ-5D utility score (mean(SD)) | 0.7 (0.3) | 0.7 (0.2) |
Clinical outcomes
Outcome | Stepped-care (n = 131) (mean (SE)) | Usual care (n = 134) (mean (SE)) | Mean difference (95% CI)b
| |
---|---|---|---|---|
Cumulative incidence of depressive/anxiety disorders | 0.29 (0.04) | 0.46 (0.04) | 0.17 (0.06 to 0.29) | |
Mean change CES-D score | 6.40 (1.05) | 3.67 (0.99) | 2.73 (−0.28 to 5.74) | |
Mean change HADS-A score | 1.88 (0.47) | 0.45 (0.51) | 1.43 (0.10 to 2.77) | |
QALY | 1.32 (0.04) | 1.28 (0.04) | 0.03 (−0.09 to 0.15) | |
Direct healthcare costs | Medication costs | 1705 (245) | 1783 (419) | −78 (−938 to 505) |
Primary care | 10,911 (1496) | 10,124 (1631) | 787 (−3754 to 4910) | |
Secondary care | 3783 (675) | 5909 (1456) | −2126 (−5911 to 348) | |
Intervention costs | 262 (34) | 0 (0) | 262 (204 to 340) | |
Total | 16,661 (1691) | 17,815 (2680) | −1154 (−7708 to 4328) | |
Indirect non healthcare costsc
| 5270 (771) | 4993 (583) | 277 (−1418 to 2230) | |
Total costs | 21,931 (2035) | 22,808 (2956) | −877 (−8039 to 5489) |
Costs
Cost utility and cost-effectiveness
Outcome | Analysis | Mean cost difference (stepped-care – usual care (bootstrapped 95% CI)) | Mean change difference (stepped-care – usual care (95% CI)) | ICER | CE-planea
| |||
---|---|---|---|---|---|---|---|---|
NE | SE | SW | NW | |||||
Disorder | Societal perspective (friction) | −877 (−8039 to 5489) | 0.17 (0.06 to 0.29) | −5159 | 41% | 59% | 0% | 0% |
Societal perspective (human capital) | 200 (−7035 to 6829) | 1176 | 53% | 47% | 0% | 0% | ||
Healthcare perspective | −1154 (−7708 to 4328) | −6788 | 37% | 63% | 0% | 0% | ||
CES-D | Societal perspective (friction) | −877 (−8039 to 5489) | 2.73 (−0.28 to 5.74) | −321 | 39% | 58% | 2% | 1% |
Societal perspective (human capital) | 200 (−7035 to 6829) | 73 | 51% | 46% | 1% | 2% | ||
Healthcare perspective | −1154 (−7708 to 4328) | −423 | 35% | 62% | 2% | 1% | ||
HADS-A | Societal perspective (friction)) | −877 (−8039 to 5489) | 1.43 (0.10 to 2.77) | −613 | 40% | 58% | 2% | 0% |
Societal perspective (human capital | 200 (−7035 to 6829) | 140 | 52% | 46% | 1% | 1% | ||
Healthcare perspective | −1154 (−7708 to 4328) | −807 | 36% | 63% | 1% | 0% | ||
QALY | Societal perspective (friction) | −877 (−8039 to 5489) | 0.03 (−0.09 to 0.15) | −29,233 | 25% | 45% | 14% | 16% |
Societal perspective (human capital) | 200 (−7035 to 6829) | 66,667 | 34% | 36% | 11% | 19% | ||
Healthcare perspective | −1154 (−7708 to 4328) | −38,467 | 23% | 48% | 16% | 13% |